Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04552691 |
|---|---|
| Brief Title: | Open-Label Expanded Access Treatment With Pegunigalsidase Alfa for Fabry Disease Patients |
| First Submitted : | September 11, 2020 |
| First Submitted that Met QC Criteria : | September 11, 2020 |
| First Posted : | September 17, 2020 |
| Last Update Submitted that Met QC Criteria : | January 21, 2021 |
| Last Update Posted : | January 25, 2021 |